| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/25/2004 | CN1524073A Crystalline forms of 'r-(r*,r*)-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-'phenylamino)carbonyl!-1h-pyrrole-1-heptanoic acid calcium salt (2:1) (atorvastatin) |
| 08/25/2004 | CN1524072A Phenyl derivatives and their use in the treatment of thromboembolic disorders or tumours |
| 08/25/2004 | CN1524007A Processes and apparatus for extraction of active substances and enriched extracts from natural products |
| 08/25/2004 | CN1524003A Composition for topical administration comprising an interleukin-2 inhibitor and an antimicrobial agent |
| 08/25/2004 | CN1524002A Treatment or prophylaxis of insulin-producing cell graft rejection |
| 08/25/2004 | CN1523995A Preventives and/or remedies for fish infections |
| 08/25/2004 | CN1523992A Compositions and methods for treating amyloidosis |
| 08/25/2004 | CN1523991A Use of c-Src inhibitors alone or in combination with STI571 for the treatment of leukaemia |
| 08/25/2004 | CN1523990A Pharmaceutical composition for treating or improving arthritis and diet extender |
| 08/25/2004 | CN1523989A Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 08/25/2004 | CN1523988A Use of nk-1 receptor antagonists for the treatment of brain, spinal or nerve injury |
| 08/25/2004 | CN1523987A Immune response modifiers for the treatment of periodontal disease |
| 08/25/2004 | CN1523986A Substituted oxazolidinones for combinational therapy |
| 08/25/2004 | CN1523985A Preparation of formulations of angiotensin ii at1 receptors antagonists for the treatment of arterial hypertension, other cardiovascular illnesses and its complications |
| 08/25/2004 | CN1523984A Drug preparations |
| 08/25/2004 | CN1523983A Method for the production of solid formulations of sodium 3-hydroxy-3-methylbutyrate |
| 08/25/2004 | CN1523982A Methods, compounds, and compositions for reducing body fat and modulating fatty acid metabolism |
| 08/25/2004 | CN1523981A A pharmaceutical tablet having a high API content |
| 08/25/2004 | CN1523980A Pharmaceutical preparation comprising an active dispersed on a matrix |
| 08/25/2004 | CN1523979A Pharmaceutical compositions of adsorbates of amorphous drug |
| 08/25/2004 | CN1523964A Infant formula supplemented with phospholipids |
| 08/25/2004 | CN1523041A Bulgaria inquinans polysaccharide, method for preparing the same and pharmaceutical composition using the compound as active component |
| 08/25/2004 | CN1523035A Medication containing 1,6-methylene-[10]-annulene-furan and steroid |
| 08/25/2004 | CN1523028A Novel phosphonate-nucleotide compound |
| 08/25/2004 | CN1523026A Process for producing sulbactam valeryl oxygen methyl ester |
| 08/25/2004 | CN1523023A Taxone bromated analog with anticancer activity and preparation method thereof |
| 08/25/2004 | CN1523019A Tricyclic triazolobenzazepine derivatives, process for producing the same, and antiallergic agents |
| 08/25/2004 | CN1523017A Oxfendazole chloride preparation and uses |
| 08/25/2004 | CN1523016A Acridine derivative and its application |
| 08/25/2004 | CN1523015A 2-amino-6-(2-substituted-4-phenoxy)-substituted-pyridines |
| 08/25/2004 | CN1523012A Novel use of acetamide derivative |
| 08/25/2004 | CN1523004A Vitamin A acid analogue and its preparing method and application |
| 08/25/2004 | CN1523003A Novel 2-(alpha-hydroxyl amyl) and its preparing method and use |
| 08/25/2004 | CN1522994A Use of plant extract of anoectochilus formosanus and fraction originating from the same as galenicals or dietary supplement for chemical defense or treatment of human malignant lesion |
| 08/25/2004 | CN1522746A Gadol pharmaceutical preparation, method for making same and uses |
| 08/25/2004 | CN1522708A Use of 2,3-0 desulphurizing heparin in preparation of drug for prevention and cure of tumour transfer |
| 08/25/2004 | CN1522707A Use of glede tea alcohol extract in preparation of antiphlogistic immune pharmaceutical |
| 08/25/2004 | CN1522706A Preparation of solid dispersoid containing large ring lactone parasite medicine |
| 08/25/2004 | CN1522705A Pharmaceutical for treating cardiovascular and cerebrovascular disease |
| 08/25/2004 | CN1522704A Parasite resistant slow release injection formulation for animals |
| 08/25/2004 | CN1522703A Yolk lecithin for injection and method for making same |
| 08/25/2004 | CN1522702A Slow and control release aspirin capsule formulation and method for making same |
| 08/25/2004 | CN1522701A Epoxy-steroidal aldosterone antagonist and angiotensin ii antagonist combination therapy |
| 08/25/2004 | CN1522700A Furfuryl sterol drop pills and method for making same |
| 08/25/2004 | CN1522699A Use of prostaglandin A1 in treatment of nerve degenerative diseases such as cerebral ischemia apoplexy |
| 08/25/2004 | CN1522698A Antivirals |
| 08/25/2004 | CN1522697A Prevention of migraine recurrence |
| 08/25/2004 | CN1522696A Compound preparation for lowering the blood pressure |
| 08/25/2004 | CN1522695A Indapamide slow release capsule and preparation method |
| 08/25/2004 | CN1522694A Medicine for treating dizziness and making method thereof |
| 08/25/2004 | CN1522693A Sodium ferulic acid osmosis pump controlled release formulation and its preparation method |
| 08/25/2004 | CN1522692A Pressurized metered dose inhalers and pharmaceutical aerosol fomulations |
| 08/25/2004 | CN1163754C Method for diagnosing a patient for chlamydia |
| 08/25/2004 | CN1163514C Synthesis method of repeated heptasaccharide uint of lentinan with antineoplastic activity |
| 08/25/2004 | CN1163509C RET ligand (RetL) for stimulating neural and renal growth |
| 08/25/2004 | CN1163502C Novel A1 adenosine receptor incitant |
| 08/25/2004 | CN1163496C Vinyl-pyrrolidone cynnematin with alkali subtituent |
| 08/25/2004 | CN1163495C Pyridine compounds, preparation method thereof and pharmaceutical compositions containing them |
| 08/25/2004 | CN1163494C Carbapenem derivative, use thereof and intermediate compound of the same |
| 08/25/2004 | CN1163492C 'Delta' 12,13-iso-taxol analogs, antineoplastic use and pharmaceutical composition containing them |
| 08/25/2004 | CN1163486C Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists |
| 08/25/2004 | CN1163485C Amlodipine-series salt and preparing process and application thereof |
| 08/25/2004 | CN1163484C 4-Aroyl-Piperidin-CCR-3 receptor antagonist III |
| 08/25/2004 | CN1163480C Styryl sulfone anticancer agent |
| 08/25/2004 | CN1163477C Substituted beta-alanine |
| 08/25/2004 | CN1163475C 4-bromo or 4-iodo phenylamino benzhydroxamic acid derivative and use as MEK inhibitor thereof |
| 08/25/2004 | CN1163466C Substituted oxobutyric acid derivative as matrix metalloprotease inhibitor |
| 08/25/2004 | CN1163274C Molded articles and method of producing the same |
| 08/25/2004 | CN1163254C Medicine for treating burn |
| 08/25/2004 | CN1163250C External application medicine for treating sweaty feet with bromidrosis |
| 08/25/2004 | CN1163249C 眼部营养素 Eye nutrients |
| 08/25/2004 | CN1163245C Disease dispelling agent |
| 08/25/2004 | CN1163239C Medicine for treating gynopathy |
| 08/25/2004 | CN1163237C Use of arsenic hexoxide (AS4O6)in preparation of Anti-cancer drug |
| 08/25/2004 | CN1163236C Biocompatible aqueous solution for use in continuous ambulatory peritoneal dialysis |
| 08/25/2004 | CN1163234C Composite biocidal particles |
| 08/25/2004 | CN1163233C Intra-cancer-cell nuclease activator |
| 08/25/2004 | CN1163232C Fatty emulsing containing reducing sugar and method for sterilizing same |
| 08/25/2004 | CN1163231C Novel galanic formulation of meloxicam for oral administration |
| 08/25/2004 | CN1163230C Remedial agent for erectile dysfunction |
| 08/25/2004 | CN1163229C Chemical graft anti-gonococcus medicinal soluble cotton yarn, and it preparation method |
| 08/25/2004 | CN1163228C Application of tea polyphenol and its oxide in treating muscular disease |
| 08/25/2004 | CN1163227C Application of tanhin polyphenolic B magnesium in preparing medicine for treating chronic hepatosis |
| 08/25/2004 | CN1163226C Oral creatin compound for treating or preventing muscle disuse syndrome |
| 08/25/2004 | CN1163225C Pharmaceutical composition containing amino-acid adduct |
| 08/25/2004 | CN1163224C Drugs for improving vesical excretory capacity |
| 08/25/2004 | CN1163222C Drug delivery system for releasing two or more active substance |
| 08/25/2004 | CN1163220C Tablet for instant and prolonged release of one or more active substances |
| 08/24/2004 | US6781950 Slider for an optical head with a terminal groove having an inclined bottom surface |
| 08/24/2004 | US6781020 Water soluble bactericide and producing method thereof |
| 08/24/2004 | US6780997 Such as dibenzyl(a,3-o-isopropylidiene-3-hydroxy-4-hydroxymethyl-2-methyl-5-pyridyl) hydroxymethylphosphonate which functions like pyridoxal-5'-phosphate in vivo; drug screening; antidiabetic agents |
| 08/24/2004 | US6780996 Process for the preparation of 7-substituted-3 quinolinecarbonitriles |
| 08/24/2004 | US6780995 Activated iododerivatives for the treatment of cancer and aids |
| 08/24/2004 | US6780994 Phthalimido arylpiperazines useful in the treatment of benign prostatic hyperplasia |
| 08/24/2004 | US6780970 Peptides for use in the treatment and prevention of diabetes, reperfusion injuries, immunological, cardiovascular and autoimune diseases |
| 08/24/2004 | US6780891 Modulate opiate receptors; central nervous system disorders |
| 08/24/2004 | US6780890 Contacting s-adenosylhomocysteine (sah with a luxs protein whereby s- adenosylhomocysteine undergoes conversion to autoinducer-2 |
| 08/24/2004 | US6780889 Prepared by mixing gamma-hydroxybutyrate and a ph-adjusting agent in an aqueous medium |
| 08/24/2004 | US6780888 Fat-soluble and stable silicon-containing derivatives of ascorbic acid |
| 08/24/2004 | US6780887 Treating and/or preventing ischemia, pathologies associated with ischemia or pathologies associated with mitochondrial deficiencies |